EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Late outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study

Florence Mycinski iD, Victor Waldmann iD, Florence Kyndt iD, Béatrice Guyomarch, Alice Maltret iD, Marie Wilkin, Caroline Ovaert iD, Guy Vaksmann iD, Jean-Benoit Thambo iD, Jean-Marc Sellal iD, Paul Padovani iD, Naychi Lwin iD und 8 weitere

Europace · 2025

DOI: 10.1093/europace/euaf040 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Europace, 2025. Verfasst von Florence Mycinski und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, F-44000 Nantes, France. Hauptthemen laut MEDLINE: Atrioventricular Block, Cardiac Pacing, Artificial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Society of Cardiology, French Federation of Cardiology, French Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The natural history of congenital or childhood non-immune, isolated atrioventricular block (AVB) is poorly defined. We aimed at clarifying its long-term outcomes. Methods and results We retrospectively studied 385 children with isolated, non-immune AVB diagnosed from in utero or up to 18 years of age, at 29 French medical centres, between 1980 and 2022. Patients with structural heart disease, endomyocardial fibrosis, or maternal antibodies were excluded. Atrioventricular block was asymptomatic in 314 (81.6%) and complete in 263 (68.3%) patients at the time of diagnosis. There was progression to complete AVB in 84/122 (68.8%) patients with incomplete AVB over 12 years (7–17). A total of 286/385 patients (74.3%) received a permanent pacemaker, implanted in the first year of life in 39 (14%) and before 10 years of age in 172 (60%) children. The pacing indication was prophylactic in 203 children (71%). Genetic screening was performed in 133/385 patients (34.5%), leading to the identification of a clinically actionable variant in 11 (8.3%) patients. After a median follow-up of 10 years (5–17), no patient died or developed endomyocardial fibrosis or dilated cardiomyopathy.

Conclusion

In this large nationwide study, the long-term outcome of congenital or childhood non-immune, isolated AVB was excellent. Most children required pacemaker implantation over time, albeit often as a prophylactic measure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrioventricular BlockCardiac Pacing, ArtificialHumansRetrospective StudiesFemaleFranceChildMaleChild, PreschoolInfantAdolescentPacemaker, ArtificialDisease ProgressionInfant, NewbornTime FactorsGenetic Testing

Stichwörter der Autor:innen

Cardiac conduction disorderClinical outcomePacemakerPaediatric electrocardiology

Autor:innen und Institutionen

  • Department of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, F-44000 Nantes, France.
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'Institut du Thorax, F-44000 Nantes, France.
  • M3C-Necker, Department of Pediatric and Congenital Cardiology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, F-75000 Paris, France.
  • Electrophysiology Unit, European Georges Pompidou Hospital, Paris, France.
  • Adult Congenital Heart Disease Unit, European Georges Pompidou Hospital, Paris, France.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

ORCID-Profile: Florence Mycinski, Victor Waldmann, Florence Kyndt, Alice Maltret, Caroline Ovaert, Guy Vaksmann, Jean-Benoit Thambo, Jean-Marc Sellal, Paul Padovani, Naychi Lwin, Oscar Werner, Julien Barc, Jean-Jacques Schott, Damien Bonnet, Vincent Probst, Alban-Elouen Baruteau

Förderung

  • French Society of Cardiology
  • French Federation of Cardiology
  • French Government
  • National Research Agency

Zitieren

APA

Mycinski, F., Waldmann, V., Kyndt, F., Guyomarch, B., Maltret, A., Wilkin, M., Ovaert, C., Vaksmann, G., Thambo, J. B., Sellal, J. M., Padovani, P., Lwin, N., Prigent, S., Werner, O., Barc, J., Schott, J. J., Bonnet, D., Probst, V., Baruteau, A. E., & Congenital AVB study group (2025). Late outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study. Europace. https://doi.org/10.1093/europace/euaf040

Vancouver

Mycinski F, Waldmann V, Kyndt F, Guyomarch B, Maltret A, Wilkin M, et al. Late outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study. Europace. 2025. doi:10.1093/europace/euaf040

BibTeX
@article{Mycinski2025,
  author = {Mycinski, Florence and Waldmann, Victor and Kyndt, Florence and Guyomarch, Béatrice and Maltret, Alice and Wilkin, Marie and Ovaert, Caroline and Vaksmann, Guy and Thambo, Jean-Benoit and Sellal, Jean-Marc and Padovani, Paul and Lwin, Naychi and Prigent, Solène and Werner, Oscar and Barc, Julien and Schott, Jean-Jacques and Bonnet, Damien and Probst, Vincent and Baruteau, Alban-Elouen and Congenital AVB study group, Congenital AVB study group},
  title = {Late outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf040}
}
Kostenlos starten →